The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human study of REGN2810, a monoclonal, fully human antibody to programmed death-1 (PD-1), in combination with immunomodulators including hypofractionated radiotherapy (hfRT).
 
Kyriakos P. Papadopoulos
Research Funding - Abbvie (Inst); ARMO BioSciences (Inst); ArQule (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Novartis (Inst); Onyx (Inst); Regeneron (Inst); Sanofi (Inst)
 
Marka R. Crittenden
Consulting or Advisory Role - Regeneron
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - MedImmune
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Melissa Lynne Johnson
Honoraria - Genentech
Consulting or Advisory Role - Astellas Pharma (I); Otsuka (I)
Research Funding - Novartis
 
Albert C. Lockhart
Research Funding - Amgen (Inst); Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Amgen (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Merrimack
 
Gerald Steven Falchook
Employment - HealthONE; Sarah Cannon Research Institute
Research Funding - 3-V Biosciences; Abbvie; Aileron Therapeutics; ARMO BioSciences; AstraZeneca; Celgene; DelMar Pharmaceuticals; eFFECTOR Therapeutics; EMD Serono; Fujifilm; Genmab; GlaxoSmithKline; Hutchison MediPharma; Incyte; Kolltan Pharmaceuticals; MedImmune; Millennium; Novartis; Regeneron; Strategia Therapeutics; Vegenics
Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy
Travel, Accommodations, Expenses - EMD Serono; Millennium; Sarah Cannon Research Institute
 
Silvia Formenti
No Relationships to Disclose
 
Richard D. Carvajal
Consulting or Advisory Role - AstraZeneca; Genentech; Janssen Oncology; Merck; Novartis
Research Funding - Amgen; Bayer Schering Pharma; Calithera Biosciences; Celldex; Daiichi Sankyo; Genentech; Incyte; Merck; Mirati Therapeutics; Novartis; Regeneron
 
Rom S. Leidner
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune
 
Aung Naing
Research Funding - Amplimmune; ARMO BioSciences; Atterocor; Baxter (I); EMD Serono; Healios; Incyte; Karyopharm Therapeutics; MedImmune; NCI; Novartis; Regeneron
Travel, Accommodations, Expenses - ARMO BioSciences
 
Lee S. Rosen
Research Funding - Lilly (Inst); Pfizer (Inst); Regeneron (Inst)
 
Glen J. Weiss
Employment - Cancer Treament Centers of America
Consulting or Advisory Role - Blend Therapeutics; Paradigm; Pharmatech
Speakers' Bureau - Amgen; Celgene; Medscape; Pfizer; Quintiles
Patents, Royalties, Other Intellectual Property - US Patent #8,911,940 issued 2014 (Inst)
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; Pharmatech
 
Wilson Caldwell Iii
Employment - Regeneron
Stock and Other Ownership Interests - Bristol-Myers Squibb; Merck; Regeneron
 
Bo Gao
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Anne Paccaly
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Elizabeth Stankevich
Employment - Regeneron
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene; Merck
 
Pamela Trail
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Matthew G. Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Consulting or Advisory Role - Egenix
Research Funding - AstraZeneca/MedImmune; Novartis; Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron (I)
 
Israel Lowy
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb; Medarex; Regeneron
Travel, Accommodations, Expenses - Regeneron